We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here's Why Lantheus Holdings (LNTH) Gained But Lagged the Market Today
Read MoreHide Full Article
Lantheus Holdings (LNTH - Free Report) closed the most recent trading day at $65.56, moving +0.55% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 1.02%. Elsewhere, the Dow saw an upswing of 0.4%, while the tech-heavy Nasdaq appreciated by 2.03%.
The diagnostic imaging company's stock has climbed by 4.76% in the past month, exceeding the Medical sector's loss of 5.2% and the S&P 500's loss of 3.15%.
The upcoming earnings release of Lantheus Holdings will be of great interest to investors. The company's earnings report is expected on May 2, 2024. The company is expected to report EPS of $1.55, up 5.44% from the prior-year quarter. In the meantime, our current consensus estimate forecasts the revenue to be $349.46 million, indicating a 16.18% growth compared to the corresponding quarter of the prior year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $6.58 per share and revenue of $1.43 billion. These totals would mark changes of +5.62% and +10.62%, respectively, from last year.
Any recent changes to analyst estimates for Lantheus Holdings should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 4.26% higher. As of now, Lantheus Holdings holds a Zacks Rank of #3 (Hold).
In terms of valuation, Lantheus Holdings is presently being traded at a Forward P/E ratio of 9.91. For comparison, its industry has an average Forward P/E of 20.69, which means Lantheus Holdings is trading at a discount to the group.
The Medical - Products industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 140, positioning it in the bottom 45% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Here's Why Lantheus Holdings (LNTH) Gained But Lagged the Market Today
Lantheus Holdings (LNTH - Free Report) closed the most recent trading day at $65.56, moving +0.55% from the previous trading session. The stock trailed the S&P 500, which registered a daily gain of 1.02%. Elsewhere, the Dow saw an upswing of 0.4%, while the tech-heavy Nasdaq appreciated by 2.03%.
The diagnostic imaging company's stock has climbed by 4.76% in the past month, exceeding the Medical sector's loss of 5.2% and the S&P 500's loss of 3.15%.
The upcoming earnings release of Lantheus Holdings will be of great interest to investors. The company's earnings report is expected on May 2, 2024. The company is expected to report EPS of $1.55, up 5.44% from the prior-year quarter. In the meantime, our current consensus estimate forecasts the revenue to be $349.46 million, indicating a 16.18% growth compared to the corresponding quarter of the prior year.
Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $6.58 per share and revenue of $1.43 billion. These totals would mark changes of +5.62% and +10.62%, respectively, from last year.
Any recent changes to analyst estimates for Lantheus Holdings should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research suggests that these changes in estimates have a direct relationship with upcoming stock price performance. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system.
The Zacks Rank system, running from #1 (Strong Buy) to #5 (Strong Sell), holds an admirable track record of superior performance, independently audited, with #1 stocks contributing an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 4.26% higher. As of now, Lantheus Holdings holds a Zacks Rank of #3 (Hold).
In terms of valuation, Lantheus Holdings is presently being traded at a Forward P/E ratio of 9.91. For comparison, its industry has an average Forward P/E of 20.69, which means Lantheus Holdings is trading at a discount to the group.
The Medical - Products industry is part of the Medical sector. Currently, this industry holds a Zacks Industry Rank of 140, positioning it in the bottom 45% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
You can find more information on all of these metrics, and much more, on Zacks.com.